Long-term follow-up of renal function after high-dose methotrexate treatment in children

Pediatric Blood and Cancer

Volumn 51, Issue 4, 2008, Pages 535-539

  Grönroos, Marika H ^a   Jahnukainen, Timo ^a,e   Möttönen, Merja ^b   Perkkiö, Mikko ^c   Irjala, Kerttu ^a,d   Salmi, Toivo T ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d Mehilainen Oy   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cancer; Children; Follow up; High dose methotrexate; Late effects; Renal function

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; BETA 2 MICROGLOBULIN; EDETATE CHROMIUM CR 51; ELECTROLYTE; GENTAMICIN; METHOTREXATE; PENTETATE TECHNETIUM TC 99M;

ADOLESCENT; ALBUMINURIA; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD PRESSURE; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DRUG MEGADOSE; ELECTROLYTE BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS; GLOMERULUS FILTRATION RATE; GLUCOSURIA; HUMAN; KIDNEY DYSFUNCTION; KIDNEY TUBULE FUNCTION; MAGNESIUM BLOOD LEVEL; MALE; NEPHROTOXICITY; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEINURIA; RETROSPECTIVE STUDY; SIDE EFFECT; SODIUM BLOOD LEVEL; URINARY EXCRETION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INFANT; KIDNEY; MALE; METHOTREXATE; NEOPLASMS; TIME FACTORS;

EID: 50249139484     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21650     Document Type: Article

References (32)

1. Launay-Vacher V, Oudard S, Janus N, et al. 2007; Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management. The Renal Insufficiency and Anticancer Medications (IRMA) Study. Cancer 2007;110:1376-1384.
2. Gustafsson G, Schmiegelow K, Forestier E, et al. Improving outcome through two decades in childhood ALL in the Nordic countries: The impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 2000;14:2267-2275.
3. Koch-Nogueira PC, Hadj-Aissa A, Schell M, et al. Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma. Pediatr Nephrol 1998;12:572-575.
4. Patte C, Auperin A, Gerrard M, et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: It is possible to reduce treatment for the early responding patients. Blood 2007;109:2773-2780.
5. Pui C-H, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166-178.
6. Timmermann B, Kortmann R-D, Kühl J, et al. Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: Results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol 2006;24:1554-1560.
7. el-Badawi MG, Abdalla MA, Bahakim HM, et al. Nephrotoxicity of low-dose methotrexate in guinea pigs: An ultrastructural study. Nephron 1996;73:462-466.
8. Grönroos M, Chen M, Jahnukainen T, et al. Methotrexate induces cell swelling and necrosis in renal tubular cells. Pediatr Blood Cancer 2006;46:624-629.
9. Condit PT, Chanes RE, Joel W. Renal toxicity of methotrexate. Cancer 1969;23:126-131.
10. Hempel L, Misselwitz J, Fleck C, et al. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function. Med Pediatr Oncol 2003;40:348-354.
11. Kaya Z, Gursel T, Bakkaloglu SA, et al. Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol 2007;24:257-267.
12. Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncologist 2006;11:694-703.
13. Bardi E, Olah A, Bartyik K, et al. Late effects on renal glomerular and tubular function in childhood cancer survivors. Pediatr Blood Cancer 2004;43:668-673.
14. Krawczuk-Rybak M, Kuzmicz M, Wysocka J. Renal function during and after treatment for acute lymphoblastic leukemia in children. Pediatr Nephrol 2005;20:782-785.
15. Schwartz GJ, Furth SL. Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol 2007;22:1839-1848.
16. Piepsz A, Colarinha P, Gordon I, et al. Guidelines for glomerular filtration rate determination in children. Eur J Nucl Med 2001;28:31-36.
17. Rehling M, Moller ML, Thamdrup B, et al. Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta- acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci (Lond) 1982;66:613-619.
18. Sposto R, Meadows AT, Chilcote RR, et al. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol 2001;37:432-441.
19. Soergel M, Kirschstein M, Busch C, et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: A multicenter trial including 1141 subjects. J Pediatr 1997;130:178-184.
20. English MW, Skinner R, Pearson ADJ, et al. Dose-related nephrotoxicity of carboplatin in children. Br J Cancer 1999;81:336-341.
21. Grönroos MH, Bolme P, Winiarski J, et al. Long-term renal function following bone marrow transplantation. Bone Marrow Transplant 2007;39:717-723.
22. Skinner R, Cotterill SJ, Stevens MCG. Risk factors for nephrotoxicity after ifosfamide treatment in children: A UKCCSG Late Effects Group study. Br J Cancer 2000;82:1636-1645.
23. Deray G, Khayat D, Cacoub P, et al. The effects of diltiazem on methotrexate-induced nephrotoxicity. Eur J Clin Pharmacol 1989;37:337-340.
24. Perazella MA. Crystal-induced acute renal failure. Am J Med 1999;106:459-465.
25. Kakihara T, Imai C, Hotta H, et al. Impaired tubular excretory function as a late renal side-effect of chemotherapy in children. J Pediatr Hematol Oncol 2003;25:209-214.
26. Barbour GL, Crumb CK, Boyd CM, et al. Comparison of inulin, iothalamate, and Tc-DTPA for measurement of glomerular filtration rate. J Nucl Med 1976;17:317-320.
27. Hjorth L, Wiebe T, Karpman D. Correct evaluation of renal glomerular filtration rate requires clearance assays. Pediatr Nephrol 2002;17:847-851.
28. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 1992;38:1933-1953.
29. Skinner R, Pearson ADJ, English MW, et al. Cisplatin dose rate as a risk factor for nephrotoxicity in children. Br J Cancer 1998;77:1677-1682.
30. Skinner R. Chronic ifosfamide nephrotoxicity in children. Med Pediatr Oncol 2003;41:190-197.
31. Yetgin S, Olgar S, Aras T, et al. Evaluation of kidney damage in patients with acute lymphoblastic leukaemia in long-term follow-up: Value of renal scan. Am J Hematol 2004;77:132-139.
32. Chow EJ, Pihoker C, Hunt K, et al. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Cancer 2007;110:2313-2320.